Search

everythinglearnresearchcommunity

for

Search:↓

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

People with Alopecia Areata are more likely to have prediabetes and obesity.

Hair helps prevent scalp skin cancer by supporting immune protection.

Human mesenchymal stem cells show promise for treating skin diseases, but more research is needed to improve treatments.

Targeting regulatory T cells may help treat age-related diseases.

Type 2 immunity helps control mite growth in hair follicles, preventing damage.

Four specific genes are linked to keloid formation and could be potential treatment targets.

Extracellular vesicles show potential in dermatology, but more research is needed for validation.

Certain cytokines may cause or be affected by immune skin diseases, suggesting possible new treatments.

Sex hormones' effects on COVID-19 are unclear and more research is needed to understand their potential as treatment.

Advancements in wound healing aim to improve personalized treatments and enhance healing outcomes.

Understanding skin reactions to radiation has improved, helping to reduce injuries and prevent skin cancer.

Targeting amphiregulin may improve treatment for fibrotic diseases and cancer.

Cannabinoids might help treat skin problems but more research is needed to be sure.

Certain immune-related proteins are higher in people with alopecia and their healthy relatives, hinting at a genetic link.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

The skin's microbiome helps hair regrow by boosting certain cell signals and metabolism.

3D human skin models show promise for dermatology but face challenges in standardization and cost.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

Alopecia areata may protect against graft dysfunction, while asthma may increase its risk.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Mesenchymal Stem/Stromal Cells (MSCs) help in wound healing and tissue regeneration, but can also contribute to tumor growth. They show promise in treating chronic wounds and certain burns, but their full healing mechanisms and potential challenges need further exploration.

Emerging therapies like JAK inhibitors show promise for hair regrowth in alopecia areata.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

S-Methylmethionine sulfonium can protect skin from UVB damage.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Pediatric alopecia areata needs more research to understand its characteristics and related conditions.

COVID-19 vaccines can cause mild to moderate skin reactions, mostly after the first dose.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.